2-(1-(4-((4-(Ethyl(2-(fluoro)ethyl)amino)phenyl)ethynyl)phenyl)ethylidene)-malononitrile was found to be a promising molecular probe in diagnosticizing tauopathies due to its favorable optical and binding properties, as well as radiofluorinating possibility. Its metabolism was predicted and a synthetic pathway of the parent molecular probe and its three predicted metabolites was proposed. Started by iodination of a commercially available aniline derivative and followed by Sonogashira coupling to mebynol, the first two steps of the syntheis of 2-(1-(4-((4-((2-(fluoro)ethyl)amino)phenyl)ethynyl)phenyl)ethylidene)-malononitrile were performed. The rest of the synthesis was designed theoretically, including the formation of terminal acetylene, Sonogashira coupling to bromoacetophenone, DAST fluorination and Knoevenagel condensation, introducing the final malononitrile.
|